Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Related Posts
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy
Lars Fruergaard Jorgensen has a problem: Too many people want what he’s selling. Mr. Jorgensen is the chief executive of…
Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risk
The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to…
Gene Therapy Allows an 11-Year-Old Boy to Hear for the First Time
Aissam Dam, an 11-year-old boy, grew up in a world of profound silence. He was born deaf and had never…